摘要
目的：观察脉律康胶囊和阿托品治疗病态窦房结综合征（ＳＳＳ）的疗效。方法：将２８０例ＳＳＳ患者随机分为治疗组（２００例）和对照组（８０例）。对照组口服阿托品，每次０．３ｍｇ～０．９ｍｇ，每日３次。治疗组口服脉律康胶囊，每次４粒，每日３次；阿托品每次０．３ｍｇ，每日３次。２组重症患者均首先静滴阿托品。２组疗程均为１个月。结果：治疗组治愈１１６例，好转７４例，无效１０例，总有效率９５．０％；对照组治愈２３例，好转３６例，无效２１例，总有效率７３．８％。治疗组总有效率明显高于对照组（χ２＝２３．２０，Ｐ＜０．０１）；副反应发生率治疗组（９．０％）显著低于对照组（２１．３％，χ２＝５．９５，Ｐ＜０．０５）。
Objective:To observe the therapeutic efficacy of Mailukang Capsule combined atropin on sick sinus syndrome (SSS).Methods:Patients of SSS (280 cases) were divided randomly into treatment group (200 cases) and control group (80 cases).The control group was treated with oral atropin 0 3 mg￣0 9 mg every time,3 times daily,while treatment group with oral Mailukang Capsule 4 pills and atropin 0 3 mg every time,3 times daily (atropin intravenous drip primarily in severe case),all 30 days as a therapy course.Results:In treatment group,116 cases were cured,74 cases were improved,10 cases were no changed,the total effective rate was 95 0%;in control group,23 cases were cured,36 cases were improved,21 cases were no changed,the total effective rate was 73 8%;the total effective rate of treatment group was higher obviously than control group (χ 2=23 20, P <0 01);the incidence of sideeffect in treatment group (9 0%) was lower obviously than control group (21 3%;χ 2=5 95, P <0 05).Conclusions:Mailukang Capsule combined atropin treating SSS are effective way.
